NO has been shown to participate in a variety of signaling pathways, including Ras, extracellular signal-regulated kinases (ERK), protein kinase B (Akt), cyclin D1/retinoblastoma (Rb), and the mammalian target of rapamycin (mTOR), which are essential for cancer cells [146]. The gene discussed is AKT1; the disease is cancer.